CACrown ArchivesThe cinema collection
Menu
Research dossier · Science & Nature

Tamsulosin

chemical compound

Specimen drawers, botanical folios and brass scientific instruments under study light
Science and natureInterpretive dossier study · Crown Archives visual atlas
Record originEnglish Wikipedia
Text licenseCC BY-SA 4.0
Source revisionJun 9, 2026
Entity authorityQ418480
Source-derived summary

Tamsulosin, sold under the brand name Flomax among others, is a medication used to treat symptomatic benign prostatic hyperplasia and chronic prostatitis. It is also used to help with the passage of kidney stones. The evidence for benefit with a kidney stone is better when the stone is larger. Tamsulosin is taken by mouth.

Common side effects include dizziness, headache, insomnia, nausea, blurry vision, and sexual problems. Other side effects may include feeling lightheaded with standing due to changes in blood pressure, and angioedema. Tamsulosin is an alpha blocker and works by relaxing muscles in the prostate. Specifically it is an α1-adrenergic receptor blocker.

Tamsulosin was approved for medical use in the United States in 1997. It is available as a generic medication.

Editorial summary

The public source identifies “Tamsulosin” as chemical compound. This brief keeps that definition visible, then builds a research path around Tamsulosin, chemical and compound.

Editorial reviewUseful for establishing the present vocabulary of the subject while preserving a route back to the evidence on which that vocabulary rests. The current lead gives the account dated anchors—1997—that can be checked directly. The selected authority fields contribute no independent date. Its value is orientation rather than verdict, with Tamsulosin, chemical and compound providing the first useful test.
Editorial analysis

Why this record matters

A short description can identify a subject without explaining its stakes. For “Tamsulosin”, the useful work is to connect “chemical compound” to the records capable of establishing context and consequence.

Evidence profile

Datasets, specimens, observations and peer-reviewed methods provide the appropriate test for the technical claims summarized here. The source revision retrieved here is dated Jun 9, 2026. The linked authority identifier is Q418480. None of the 0 selected statements returned an explicit reference. The first chronological checks are 1997.

Critical limits

Current terminology should not be projected backward without checking the classification used when the underlying evidence was created. The source lead contains qualifying language; that uncertainty should survive quotation, summary and reuse. Authority statements aid reconciliation but still require their own references, qualifiers and ranks to be checked.

How to read it

Check terminology, classification and the date of the cited evidence. Scientific names and technical consensus can change while older records retain historical value.

Best used for
  • Current terminology
  • Classification context
  • Finding cited technical literature
Verify next

Primary datasets, specimen catalogues, standards bodies and the most recent peer-reviewed literature.

Three-step research path

  1. Establish the record: confirm the title “Tamsulosin”, its source revision and the description used here.
  2. Expand the search: follow Tamsulosin primary sources, Tamsulosin archive and Tamsulosin research across catalogues and specialist indexes.
  3. Test the account: compare the strongest cited source with the responsible institution’s current record and note any disagreement.

Questions for further research

  1. Which source most directly establishes the central claim about “Tamsulosin”?
  2. Has classification or technical consensus changed since the cited source?
  3. Which observation, specimen, dataset or publication supports the account?
Subject index

Search terms from this dossier

Source & attribution

This entry incorporates text from Tamsulosin” on English Wikipedia. Contributors are listed in the page history. Text is available under the Creative Commons Attribution-ShareAlike 4.0 License. Selected authority identifiers and statements are retrieved from Wikidata under CC0; their references and qualifiers remain part of the verification path.